MemoBoost Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

MemoBoost General Information

Description

Developer of a drug designed to inhibit the onset of dementia. The company's technology is based on research into the scientific foundations of learning and memory in the brain, helping patients to serve as a potent cognitive enhancer to tackle the onset of dementia and other cognitive deficits.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Abba Khoushy Avenue 199
  • Haifa
  • Israel
Primary Industry
Drug Discovery
Vertical(s)
HealthTech
Corporate Office
  • Abba Khoushy Avenue 199
  • Haifa
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MemoBoost Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Startup
1. Seed Round 01-Jun-2016 Completed Startup
To view MemoBoost’s complete valuation and funding history, request access »

Ready to get started?

Request a free trial

MemoBoost FAQs

  • When was MemoBoost founded?

    MemoBoost was founded in 2016.

  • Where is MemoBoost headquartered?

    MemoBoost is headquartered in Haifa, Israel.

  • What industry is MemoBoost in?

    MemoBoost’s primary industry is Drug Discovery.

  • Is MemoBoost a private or public company?

    MemoBoost is a Private company.

  • What is MemoBoost’s current revenue?

    The current revenue for MemoBoost is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process